Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hocher, B.
Right arrow Articles by Neumayer, H.-H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hocher, B.
Right arrow Articles by Neumayer, H.-H.
J Am Soc Nephrol 14:2329-2337, 2003
© 2003 American Society of Nephrology

Different Impact of Biomarkers as Mortality Predictors among Diabetic and Nondiabetic Patients Undergoing Hemodialysis

Berthold Hocher*, Reinhard Ziebig{dagger}, Claudia Altermann{dagger}, Rolfdieter Krause{ddagger}, Gernot Asmus§, Claus-Michael Richter*, Torsten Slowinski*, Pranav Sinha{dagger} and Hans-H. Neumayer*

*Department of Nephrology and {dagger}Institute of Laboratory Medicine, University Hospital Charité, Humboldt University of Berlin, Berlin, Germany; {ddagger}Kuratorium für Heimdialyse Dialysezentrum Moabit, Berlin, Germany; and §Kuratorium für Heimdialyse Dialysezentrum Sonnenallee, Berlin, Germany.

Correspondence to Dr. Berthold Hocher, Universitätsklinikum Charité der Humboldt Universität zu Berlin, Klinik für Nephrologie, Schumannstrasse 20-21, D-10098 Berlin, Germany. Phone: +49-30-450514098; Fax: +49-30-450514938;

ABSTRACT. Diabetic patients undergoing hemodialysis demonstrate much worse survival rates than do nondiabetic patients undergoing hemodialysis. To search for risk predictors, a prospective cohort study was performed with 245 hemodialysis patients, including 84 with diabetes mellitus, for 2 yr. C-reactive protein, troponin T (TnT), total, HDL, LDL, and lipoprotein(a) cholesterol, apoA2, apoB, triglyceride, fibrinogen, D-dimer, albumin, and creatinine levels and clinical characteristics at the time of entry were recorded. Survival rates were compared with Kaplan-Meier and Cox regression analyses. Forty-three diabetic patients and 30 nondiabetic patients died. Among diabetic patients, oliguria (<200 ml/d) (relative risk, 3.24; 95% confidence interval, 1.63 to 6.41; P = 0.001), elevated C-reactive protein levels (relative risk, 2.57; 95% confidence interval, 1.06 to 6.18; P = 0.035), and elevated D-dimer levels (relative risk, 2.36; 95% confidence interval, 1.11 to 5.01; P = 0.025) predicted all-cause mortality rates. Oliguria was by far the most important predictor, particularly for infectious disease-related death (relative risk, 23.35; 95% confidence interval, 2.60 to 209.97; P = 0.005). Among nondiabetic patients, elevated TnT levels (relative risk, 4.00; 95% confidence interval, 1.58 to 10.10; P = 0.003), elevated D-dimer levels (relative risk, 3.45; 95% confidence interval, 1.27 to 9.33; P = 0.015), and low cholesterol levels (relative risk, 3.61; 95% confidence interval, 1.34 to 9.71; P = 0.011) predicted all-cause mortality rates. Subdivision of the causes of death among nondiabetic patients revealed that TnT levels predicted cardiovascular mortality rates (relative risk, 5.38; 95% confidence interval, 1.11 to 26.10; P = 0.037) and infectious disease-related mortality rates (relative risk, 12.02; 95% confidence interval, 1.42 to 191.96; P = 0.023). In conclusion, mortality predictors among patients undergoing hemodialysis differed substantially between diabetic and nondiabetic patients. Strategies to reduce mortality rates should consider these differences. E-mail: berthold.hocher@charite.de




This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
R. Wiessner, K. Hannemann-Pohl, R. Ziebig, H. Grubitzsch, B. Hocher, O. Vargas-Hein, A. Lun, I. Schimke, and L. Liefeldt
Impact of kidney function on plasma troponin concentrations after coronary artery bypass grafting
Nephrol. Dial. Transplant., January 1, 2008; 23(1): 231 - 238.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
J. Ajiro, B. Alchi, I. Narita, K. Omori, D. Kondo, M. Sakatsume, J. J. Kazama, K. Akazawa, and F. Gejyo
Mortality Predictors after 10 Years of Dialysis: A Prospective Study of Japanese Hemodialysis Patients
Clin. J. Am. Soc. Nephrol., July 1, 2007; 2(4): 653 - 660.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
B. Hocher, L. Liefeldt, T. Quaschning, P. Kalk, R. Ziebig, M. Godes, K. Relle, G. Asmus, and J.-P. Stasch
Soluble CD154 Is a Unique Predictor of Nonfatal and Fatal Atherothrombotic Events in Patients Who Have End-Stage Renal Disease and Are on Hemodialysis
J. Am. Soc. Nephrol., April 1, 2007; 18(4): 1323 - 1330.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
B. C.H. Kwan, F. Kronenberg, S. Beddhu, and A. K. Cheung
Lipoprotein Metabolism and Lipid Management in Chronic Kidney Disease
J. Am. Soc. Nephrol., April 1, 2007; 18(4): 1246 - 1261.
[Full Text] [PDF]


Home page
CirculationHome page
T. W. Wallace, S. M. Abdullah, M. H. Drazner, S. R. Das, A. Khera, D. K. McGuire, F. Wians, M. S. Sabatine, D. A. Morrow, and J. A. de Lemos
Prevalence and Determinants of Troponin T Elevation in the General Population
Circulation, April 25, 2006; 113(16): 1958 - 1965.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
N. A. Khan, B. R. Hemmelgarn, M. Tonelli, C. R. Thompson, and A. Levin
Prognostic Value of Troponin T and I Among Asymptomatic Patients With End-Stage Renal Disease: A Meta-Analysis
Circulation, November 15, 2005; 112(20): 3088 - 3096.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
H. Izzedine, V. Launay-Vacher, G. Peytavin, M. A. Valantin, and G. Deray
Atazanavir: a novel inhibitor of HIV-protease in haemodialysis
Nephrol. Dial. Transplant., April 1, 2005; 20(4): 852 - 853.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
V. Regitz-Zagrosek, E. Lehmkuhl, B. Hocher, D. Goesmann, H. B. Lehmkuhl, H. Hausmann, and R. Hetzer
Gender as a risk factor in young, not in old, women undergoing coronary artery bypass grafting
J. Am. Coll. Cardiol., December 21, 2004; 44(12): 2413 - 2414.
[Full Text] [PDF]


Home page
CirculationHome page
B. Hocher, R. Ziebig, R. Krause, G. Asmus, H.-H Neumayer, L. Liefeldt, and J.-P. Stasch
Relaxin Is an Independent Risk Factor Predicting Death in Male Patients With End-Stage Kidney Disease
Circulation, May 18, 2004; 109(19): 2266 - 2268.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP